Taiwan makes public Medigen COVID-19 vaccine contract

The Centers for Disease Control (CDC) on Tuesday published the contract it used to purchase the COVID-19 vaccine made by Taiwan-based Medigen Vaccine Biologics Corp. in 2021, in an effort to put an end to ongoing accusations that the deal lacked transparency.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)